Really a sad fact.
Los Angeles hospital pays $17,000 ransom to get its computer system unlocked. Expert says hackers find medical institutions as easy, profitable targets.
Really a sad fact.
Los Angeles hospital pays $17,000 ransom to get its computer system unlocked. Expert says hackers find medical institutions as easy, profitable targets.
So, we’re now adding possible murder to the charges of hackers?.
The Hollywood Presbyterian Medical Center in Los Angeles paid a ransom of 17,000 U.S. dollars to hackers after two weeks of being shut out of their computer network. We talk to cyber security expert Jay Radcliffe about medical cyber vulnerabilities.
Overview.
What is the MMTP? The MMTP is an ambitious project, designed to radically speed up the rate of progress in the field of regenerative medicine and aging research.
The project is the brainchild of our parent organisation, The International Longevity Alliance, a nonprofit foundation for science advocacy and research. The testing and discovery of compounds and treatments to delay or stop the processes of aging is a slow affair, with very few high quality, high impact studies conducted each year.
A new chip designed for the brain is now wireless. Now that it is no longer connected using wires, will it compromise its accuracy?
The Nanyang Technological University in Singapore has developed a smart chip that can be used for neural implants in order to wirelessly transmit brain signals to the rest of the body with 95% accuracy. These neural implants, and the data that they register, are expected to help curtail symptoms of diseases like Parkinson’s, and they could also help paraplegic patients move their prosthetic limbs.
For operations, external devices can use the the 5mm by 5mm chip to receive and analyze data before sending back important details, instead of sending the entire data stream all at once. This drastically decreases its power consumption, making the tech far more viable.
Researchers have developed a functioning miniature replica of the human brain, composed of neurons and glial cells, to help study and better understand neurological diseases.
A tiny ball of brain cells may help researchers alleviate or treat neurological diseases.
These small cellular balls act like miniature versions of the human brain, mimicking various aspects of the actual brain that include sending pulses of electric signals akin to what happens in a thinking mind. This research was reported at the annual meeting of the American Association for the Advancement of Science in Washington.
The facts about the CRISPR Patent.
Xconomy San Francisco —
If you ask people who don’t follow biotech too closely what they know about CRISPR, you might get two answers: genetic editing and a big patent fight.
But a new CRISPR patent highlights a lower-profile potential use for the biotechnology: genetic detection and analysis.
New insights on GBM resistance markers.
A research team, with the participation of the University of Granada (UGR), has made some progress in determining the causes for glioblastoma multiforme (GBM), one of the most aggressive brain tumors known, to be resistant to the drugs currently used, which is one of the main limitations of its treatment. The results have been recently published in two articles in PlosOne magazine.
The researchers have proven that proteoglycans (the cells’ structural elements), called decorin (DCN) and lumican (LUM), could be decisive in the behavior and development of a resistance to the drugs used for treating glioblastoma multiforme, such as temozolamide (TMZ). In the other hand, they have laid bare that the inhibition of the transcription of some of the sub-units belonging to the mismatch-repair (MMR) complex, a system that analyzes and repairs DNA, could be responsible of the failure of current therapies against this kind of tumor.
This is a scientific breakthrough that could be useful for the search of new resistance markers in GBM as well as for the development of new therapeutic strategies which avoid the resistance to drugs that these tumors possess.
Absolutely; it will and that is the real danger in technology. This is why security roles will be increasingly in demand over the next 7 to 10 years.
Kaspersky director Marco Preuss looks at the future of biometric technology and bio-cybersecurity.
Neural networks have become enormously successful – but we often don’t know how or why they work. Now, computer scientists are starting to peer inside their artificial minds.
A PENNY for ’em? Knowing what someone is thinking is crucial for understanding their behaviour. It’s the same with artificial intelligences. A new technique for taking snapshots of neural networks as they crunch through a problem will help us fathom how they work, leading to AIs that work better – and are more trustworthy.
In the last few years, deep-learning algorithms built on neural networks – multiple layers of interconnected artificial neurons – have driven breakthroughs in many areas of artificial intelligence, including natural language processing, image recognition, medical diagnoses and beating a professional human player at the game Go.
The trouble is that we don’t always know how they do it. A deep-learning system is a black box, says Nir Ben Zrihem at the Israel Institute of Technology in Haifa. “If it works, great. If it doesn’t, you’re screwed.”
Neural networks are more than the sum of their parts. They are built from many very simple components – the artificial neurons. “You can’t point to a specific area in the network and say all of the intelligence resides there,” says Zrihem. But the complexity of the connections means that it can be impossible to retrace the steps a deep-learning algorithm took to reach a given result. In such cases, the machine acts as an oracle and its results are taken on trust.
To address this, Zrihem and his colleagues created images of deep learning in action. The technique, they say, is like an fMRI for computers, capturing an algorithm’s activity as it works through a problem. The images allow the researchers to track different stages of the neural network’s progress, including dead ends.
More than half of terminally ill blood cancer patients experienced complete remission in early clinical trials.
More info: http://ow.ly/YoWWv please help spread the word by sharing!